Abernethy DR[au] - Search Results

Year	Number of Results
1972	1
1977	1
1978	1
1981	10
1982	15
1983	33
1984	24
1985	15
1986	16
1987	16
1988	8
1989	6
1990	7
1991	6
1992	4
1993	5
1994	2
1995	3
1996	3
1997	8
1998	6
1999	7
2000	7
2001	2
2002	5
2003	4
2004	5
2005	3
2006	4
2007	7
2008	8
2009	6
2010	7
2011	5
2012	7
2013	2
2014	3
2015	9
2016	4
2017	4
2018	4
2019	3
2021	0

1

Pharmacokinetics and clinical effectiveness of methylphenidate.

Kimko HC, Cross JT, Abernethy DR. Kimko HC, et al. Among authors: abernethy dr. Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.

2

Effect of obesity on the pharmacokinetics of drugs in humans.

Hanley MJ, Abernethy DR, Greenblatt DJ. Hanley MJ, et al. Among authors: abernethy dr. Clin Pharmacokinet. 2010;49(2):71-87. doi: 10.2165/11318100-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20067334 Review.

3

Pharmacokinetics and pharmacodynamics of amlodipine.

Abernethy DR. Abernethy DR. Cardiology. 1992;80 Suppl 1:31-6. doi: 10.1159/000175050. Cardiology. 1992. PMID: 1534713

4

IUPHAR International geriatric clinical pharmacology curriculum for medical students.

Kashyap M, Thuermann P, Le Couteur DG, Abernethy DR, Hilmer SN. Kashyap M, et al. Among authors: abernethy dr. Pharmacol Res. 2019 Mar;141:611-615. doi: 10.1016/j.phrs.2019.01.032. Epub 2019 Jan 17. Pharmacol Res. 2019. PMID: 30660820 No abstract available.

5

A drug burden index to define the functional burden of medications in older people.

Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, Harris TB, Hanlon JT, Rubin SM, Shorr RI, Bauer DC, Abernethy DR. Hilmer SN, et al. Among authors: abernethy dr. Arch Intern Med. 2007 Apr 23;167(8):781-7. doi: 10.1001/archinte.167.8.781. Arch Intern Med. 2007. PMID: 17452540

6

Pediatric dose selection.

Abernethy DR, Burckart GJ. Abernethy DR, et al. Clin Pharmacol Ther. 2010 Mar;87(3):270-1. doi: 10.1038/clpt.2009.292. Clin Pharmacol Ther. 2010. PMID: 20160747 Review.

7

Calcium-antagonist drugs.

Abernethy DR, Schwartz JB. Abernethy DR, et al. N Engl J Med. 1999 Nov 4;341(19):1447-57. doi: 10.1056/NEJM199911043411907. N Engl J Med. 1999. PMID: 10547409 Review. No abstract available.

8

Tyrosine kinase-targeting drugs-associated heart failure.

Gronich N, Lavi I, Barnett-Griness O, Saliba W, Abernethy DR, Rennert G. Gronich N, et al. Among authors: abernethy dr. Br J Cancer. 2017 May 9;116(10):1366-1373. doi: 10.1038/bjc.2017.88. Epub 2017 Apr 11. Br J Cancer. 2017. PMID: 28399109 Free PMC article.

9

Metal impurities in food and drugs.

Abernethy DR, Destefano AJ, Cecil TL, Zaidi K, Williams RL; USP Metal Impurities Advisory Panel. Abernethy DR, et al. Pharm Res. 2010 May;27(5):750-5. doi: 10.1007/s11095-010-0080-3. Epub 2010 Mar 9. Pharm Res. 2010. PMID: 20217462 Review.

10

In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods.

Yoshida K, Zhao P, Zhang L, Abernethy DR, Rekić D, Reynolds KS, Galetin A, Huang SM. Yoshida K, et al. Among authors: abernethy dr. J Pharm Sci. 2017 Sep;106(9):2209-2213. doi: 10.1016/j.xphs.2017.04.045. Epub 2017 Apr 26. J Pharm Sci. 2017. PMID: 28456729 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results